In midst of country’s third wave, Nigeria kicks off second phase of COVID-19 vaccination rollout.
On Monday, Nigeria launched the second phase of its COVID-19 vaccination rollout following the successful delivery of Moderna and J&J vaccines. The country received over 4 million doses of the Moderna vaccine donated by the U.S. government through the COVAX facility and 117, 600 doses of J&J vaccines through the African Union led initiative. The phase 2 rollout which includes vaccines to be administered to 18-year-olds and above in the 36 states and the Federal Capital Territory forms part of a continuous effort towards curbing the spread of the disease in the country. Boss Mustapha, Chairman of the Presidential Steering Committee on COVID-19, said the arrival of Moderna and Johnson and Jonson vaccines will enhance the government's effort to get more Nigerians vaccinated to achieve herd immunity against the disease.
“Achieving herd immunity is a collective responsibility of everyone and so we need to advise everyone to receive the vaccine. We have the responsibility to safeguard the health of the people and the government will ensure the availability of vaccines. The vaccines are safe and efficacious,” he said. The country expects additional 42.5m doses of different vaccine products from the COVAX facility, African Union, and donations from the U.S., UK and other countries to be used for the second phase vaccination. Last month, the Nigeria Centre for Disease Control (CDC) said it had detected the Delta variant, putting officials on alert for a third wave of infections in the country. To date, the virus has killed 2,223 people and infected nearly 183,087 in Nigeria according to data retrieved from the Africa CDC.